Four categories of statin-induced myopathy can be distinguished: myositis, self-limited toxic statin myopathy, myalgia or increased creatine kinase, and rhabdomyolysis (i.e. the recently described IMNM with anti-HMGCR antibodies) [6]. This evidence concerns the gene HMGCR and myositis disease.